Medicines Discovery Catapult (MDC) and the Francis Crick Institute have announced a new strategic partnership to support the delivery of KQ Labs, a national accelerator for data-driven health science start-ups.
OneChain Immunotherapeutics (OCI), a clinical-stage biotech company focused on the development of CAR-T therapies for the treatment of oncologic diseases, has announced the appointment of Barbara Krebs-Pohl as the new chair of the Board of Directors.
iOnctura, a clinical-stage biopharmaceutical company, has announced the appointments of Steven Sciuto as chief financial officer (CFO) and Michelle Tsai PharmD as chief operating officer (COO).
Clinigen, the global specialty pharmaceutical services group, has highlighted a key collaborative milestone with Shionogi, an impact-driven pharmaceutical company, marking the launch of their new strategic relationship.
Nuclera, the biotechnology company accelerating protein expression and optimisation through its benchtop eProtein Discovery System, has announced a collaboration with Cytiva.
Bachem has announced investment across their site network, with new funding to improve production facilities at their Bubendorf, Vista and St Helens sites, along with a new site in Sisseln.
Cinclus Pharma Holding has announced an agreement with Zentiva, a European pharmaceutical company, for the commercialisation and manufacturing of its lead asset, linaprazan glurate, in Europe.
Shilpa Biologicals, a full-service contract development and manufacturing organisation (CDMO), announces the opening of a dedicated bioconjugation suite at its Dharwad site in India.
Kaida BioPharma, an earlystage pharma company dedicated to advancing targeted anti-cancer therapies to address hormone-driven cancers affecting women, has entered into a manufacturing agreement with Northway Biotech, for the manufacturing of KAD101.
Mirai Bio (Mirai) has announced a strategic collaboration with Thermo Fisher Scientific to benefit the life sciences and genetic medicines marketplace.
GC Biopharma, a South Korean biopharmaceutical company, has partnered with global tech leader Körber to implement a large-scale Manufacturing Execution System (MES) project across multiple sites.
Capula, a specialist in advanced operational technology and industrial digitalisation, has announced a partnership with Dimension Software, a New Zealand-headquartered global provider of operational intelligence solutions.